Subgroups
Bayer HealthCare
-
Wednesday - April 22, 2009
Anniversary
Pioneering diabetes management
Bayer HealthCare celebrates 40 years of innovative blood glucose monitoring
-
Thursday - April 2, 2009
European Nutritionals Press Workshop
Inadequate micronutrient status is more common than expected
Dietary supplements are key to maintaining health and well-being throughout life cycle
-
Friday - March 27, 2009
Bayer Offers New Betaferon® Titration Pack
Easy-to-use pack is designed to improve patient acceptance of therapy right from the start
-
Thursday - March 19, 2009
Venous Blood Clot Prevention after Hip or Knee Replacement Surgery:
U.S. FDA Advisory Committee supports favorable benefit-risk profile of Bayer’s rivaroxaban
-
Wednesday - March 18, 2009
Targeted therapies in renal cell cancer:
Optimizing the overall treatment regimen through proactive management & patient-focused treatment options
-
Wednesday - March 18, 2009
Bayer HealthCare enters into a strategic partnership:
Bayer and Tsinghua University (Institute of Biomedicine) establish joint research center in China
-
Thursday - March 5, 2009
The sky is the limit
“I’m living my wildest dreams”
World-class snowboarder Chris Southwell successfully fits diabetes into his lifestyle
-
Tuesday - March 3, 2009
Spring Financial News Conference
Full Year 2008 Results
-
Wednesday - February 25, 2009
Deadline for application: March 25, 2009
Advances in Renal Cancer Journalists’ Award
Association of German Medical Journalists and Bayer HealthCare honor outstanding reporting on renal cancer
-
Thursday - February 12, 2009
Bayer Schering Pharma to invest 100 million Euro in China to build a global R&D center
-
Monday - February 9, 2009
Development of riociguat is progressing well:
Bayer Schering Pharma Starts Phase III Program of New Drug Against Pulmonary Hypertension
-
Friday - January 16, 2009
Advances in Renal Cancer Journalists’ Award: closing date for applications is February 28, 2009
Association of German Medical Journalists and Bayer HealthCare honor outstanding reporting on renal cancer
-
Monday - January 12, 2009
Bayer Schering Pharma signs agreement with Micromet:
Exclusive licensing option for solid tumor antibody
-
Thursday - January 8, 2009
Molecular Imaging:
Bayer Schering Pharma enhances research in cancer imaging
Licensing agreement with Hamamatsu Photonics K.K., Japan
-
Wednesday - January 7, 2009
Visanne® - new long-term treatment for endometriosis submitted for registration in Europe
-
Thursday - December 18, 2008
Study presented of diabetes technology society meeting finds in-office A1CNow+ monitor demonstrates precision and accuracy in A1C testing
-
Friday - December 12, 2008
Bayer's Perspective on Innovation 2008
-
Friday - December 12, 2008
New Technologies and Products Presented at the Perspective on Innovation 2008:
Bayer Strengthens Research and Development
Bayer innovations provide solutions for the global challenges of the future / Pharmaceutical pipeline is well filled, with 50 projects currently in phases I to III of clinical testing / Ten new crop protection active ingredients are to come onto the market between 2008 and 2012 / Bayer Chairman Wenning calls for tax breaks for research and development, better patent protection, increased efforts in education policy and a higher acceptance of technology
-
Monday - December 8, 2008
Venous Blood Clot Prevention after Knee or Hip Replacement Surgery:
Xarelto® Reduces Symptomatic VTE and Death Following Knee or Hip Replacement Surgery by More Than 50% Compared to Enoxaparin in Pooled Analysis of RECORD Clinical Trial Program
Pooled Analysis of RECORD1-4 Trials Confirms Significant Benefit in Clinical Outcomes for Patients Treated with Xarelto / RECORD4 Study Demonstrates Xarelto is the Only Oral Anticoagulant to Show Clinical Benefit in Head-to-Head Comparison Against U.S.-Approved Regimen of Enoxaparin
Search
Publications
Stockholders' Newsletter
Annual Report
Sustainable Development Report
The Bayer Climate Program
research – The Bayer Scientific Magazine
Publications Overview
Newsletter
EventsFriday, February 26, 2010
Annual Report 2009 / Financial News Conference Full Year 2009
Contact: Günter Forneck
Additional Press Events
Investor Relations Events
Sport Events
BayKomm Events
Download Center - Selection